Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: July 8, 2004
Last updated: April 9, 2014
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)